Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Single-cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer.

Taverna JA, Hung CN, DeArmond DT, Chen M, Lin CL, Osmulski PA, Gaczynska ME, Wang CM, Lucio ND, Chou CW, Chen CL, Nazarullah A, Lampkin SR, Qiu L, Bearss DJ, Warner S, Whatcott CJ, Mouritsen L, Wade M, Weitman S, Mesa RA, Kirma NB, Chao WT, Huang TH.

Cancer Res. 2020 Jan 28. pii: canres.3183.2019. doi: 10.1158/0008-5472.CAN-19-3183. [Epub ahead of print]

PMID:
31992541
2.

Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression.

Li X, Shepard HM, Cowell JA, Zhao C, Osgood RJ, Rosengren S, Blouw B, Garrovillo SA, Pagel MD, Whatcott CJ, Han H, Von Hoff DD, Taverna DM, LaBarre MJ, Maneval DC, Thompson CB.

Clin Cancer Res. 2018 Oct 1;24(19):4798-4807. doi: 10.1158/1078-0432.CCR-17-3284. Epub 2018 Jul 3.

3.

Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer.

Whatcott CJ, Ng S, Barrett MT, Hostetter G, Von Hoff DD, Han H.

PLoS One. 2017 Aug 25;12(8):e0183871. doi: 10.1371/journal.pone.0183871. eCollection 2017.

4.

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Borazanci E, Millis SZ, Korn R, Han H, Whatcott CJ, Gatalica Z, Barrett MT, Cridebring D, Von Hoff DD.

World J Gastrointest Oncol. 2015 Sep 15;7(9):132-40. doi: 10.4251/wjgo.v7.i9.132. Review.

5.

Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction.

Whatcott CJ, Han H, Von Hoff DD.

Cancer J. 2015 Jul-Aug;21(4):299-306. doi: 10.1097/PPO.0000000000000140. Review.

6.

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.

Whatcott CJ, Diep CH, Jiang P, Watanabe A, LoBello J, Sima C, Hostetter G, Shepard HM, Von Hoff DD, Han H.

Clin Cancer Res. 2015 Aug 1;21(15):3561-8. doi: 10.1158/1078-0432.CCR-14-1051. Epub 2015 Feb 18.

7.

Desmoplasia and chemoresistance in pancreatic cancer.

Whatcott CJ, Posner RG, Von Hoff DD, Han H.

In: Grippo PJ, Munshi HG, editors. Pancreatic Cancer and Tumor Microenvironment. Trivandrum (India): Transworld Research Network; 2012. Chapter 8.

8.

Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.

Whatcott CJ, Han H, Posner RG, Hostetter G, Von Hoff DD.

Cancer Discov. 2011 Sep;1(4):291-6. doi: 10.1158/2159-8290.CD-11-0136.

9.

A specific isoform of poly(ADP-ribose) glycohydrolase is targeted to the mitochondrial matrix by a N-terminal mitochondrial targeting sequence.

Whatcott CJ, Meyer-Ficca ML, Meyer RG, Jacobson MK.

Exp Cell Res. 2009 Dec 10;315(20):3477-85. doi: 10.1016/j.yexcr.2009.04.005. Epub 2009 Apr 21.

10.

Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity.

Meyer RG, Meyer-Ficca ML, Whatcott CJ, Jacobson EL, Jacobson MK.

Exp Cell Res. 2007 Aug 1;313(13):2920-36. Epub 2007 Apr 19.

Supplemental Content

Loading ...
Support Center